(Q41888758)

13 October 2017

0 references

Malignant hypercalcaemia (English)

1 reference

13 October 2017

Stevenson JC

1

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 August 1985

1 reference

13 October 2017

1 reference

13 October 2017

291

1 reference

13 October 2017

6493

1 reference

13 October 2017

421-422

1 reference

The hypercalcemia of malignancy: pathogenesis and management

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

An interleukin 1 like factor stimulates bone resorption in vitro.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Role of glucocorticoids in management of malignant hypercalcaemia.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Salmon Calcitonin in the Treatment of Hypercalcemia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Prostaglandins and breast cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Malignancy-Associated Hypercalcemia: Evaluation with a Cytochemical Bioassay for Parathyroid Hormone*

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1416311

Failure of corticosteroid therapy to correct the hypercalcaemia of malignant disease

18 August 2018

1 reference

12 December 2020

Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy

1 reference

12 December 2020

Hypercalcaemia--a hospital survey

1 reference

12 December 2020

Comparison of two parenteral diphosphonates in hypercalcemia of malignancy

1 reference

12 December 2020

Rehydration in the treatment of severe hypercalcaemia

1 reference

12 December 2020

Hypercalcaemia and metastatic bone disease: is there a causal link?

1 reference

12 December 2020

A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog

1 reference

12 December 2020

Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy

1 reference

12 December 2020

Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.291.6493.421

0 references

1 reference

13 October 2017

PubMed publication ID

3926225

1 reference